2022 the Japanese Society of Medical Oncology Annual Meeting

Presentation information

Print

Mini-Oral Session

[MO29] Mini-Oral Session 29　Lung Cancer / Thoracic Cancer 4（EGFR-TKI 1）
【E】

Fri. Feb 18, 2022 9:55 AM - 10:45 AM Room 13 (Gold Room, B2F, The Prince Kyoto Takaragaike)

Chair：Kazuma Kishi（Department of Respiratory Medicine, Toho University），Toshiyuki Kozuki（Clinical Research Center, National Hospital Organization Shikoku Cancer Center）

[MO29-2] Efficacy of dacomitinib in re-treatment setting for patients with EGFR mutant NSCLC (TOPGAN2020-02)

○Hiroaki Sakamoto1, Hisashi Tanaka2, Fumiyoshi Ohyanagi3, Yousuke Kawashima4, Yuichi Tambo5, Azusa Tanimoto6, Atsushi Horiike7, Eisaku Miyauchi8, Yuko Tsuchiya9, Makoto Nishio1 (1.Department of Thoracic Medical Oncology, Cancer Institute Hospital, Japanese Foundation For Cancer Research, 2.Department of Respiratory Medicine, Hirosaki University Graduate School of Medicine, 3.Division of Pulmonary Medicine, Clinical Department of Internal Medicine, Jichi Medical University Saitama Medical Center, 4.Department of Pulmonary Medicine, Sendai Kousei Hospital, 5.Department of Respiratory Medicine, Kanazawa University Hospital, 6.Division of Medical Oncology, Cancer Research Institute, Kanazawa University, 7.Division of Medical Oncology, Department of Medicine, Showa University School of Medicine, 8.Department of Respiratory Medicine, Tohoku University Graduate School of Medicine, 9.Department of Respiratory Medicine, Kitakyushu Municipal Medical Center)

Abstract password authentication.
The password can be found on page 27 of the program book.

Password